257 related articles for article (PubMed ID: 12464871)
21. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
[TBL] [Abstract][Full Text] [Related]
22. Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis.
Jacobi J; Tam BY; Sundram U; von Degenfeld G; Blau HM; Kuo CJ; Cooke JP
Gene Ther; 2004 Feb; 11(3):302-9. PubMed ID: 14737090
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
[TBL] [Abstract][Full Text] [Related]
24. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus amplicon delivery of a hypoxia-inducible soluble vascular endothelial growth factor receptor (sFlk-1) inhibits angiogenesis and tumor growth in pancreatic adenocarcinoma.
Reinblatt M; Pin RH; Bowers WJ; Federoff HJ; Fong Y
Ann Surg Oncol; 2005 Dec; 12(12):1025-36. PubMed ID: 16244806
[TBL] [Abstract][Full Text] [Related]
26. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
Mahasreshti PJ; Kataram M; Wang MH; Stockard CR; Grizzle WE; Carey D; Siegal GP; Haisma HJ; Alvarez RD; Curiel DT
Clin Cancer Res; 2003 Jul; 9(7):2701-10. PubMed ID: 12855650
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
28. Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas.
Kaliberov SA; Kaliberova LN; Buchsbaum DJ
Gene Ther; 2005 Mar; 12(5):407-17. PubMed ID: 15616600
[TBL] [Abstract][Full Text] [Related]
29. Effect of recombinant adenovirus vector mediated human interleukin-24 gene transfection on pancreatic carcinoma growth.
Pan XT; Zhu QY; Li DC; Yang JC; Zhang ZX; Zhu XG; Zhao H
Chin Med J (Engl); 2008 Oct; 121(20):2031-6. PubMed ID: 19080270
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
31. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
[TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.
Kuo CJ; Farnebo F; Yu EY; Christofferson R; Swearingen RA; Carter R; von Recum HA; Yuan J; Kamihara J; Flynn E; D'Amato R; Folkman J; Mulligan RC
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4605-10. PubMed ID: 11274374
[TBL] [Abstract][Full Text] [Related]
34. Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models.
Wang L; Yao B; Li Q; Mei K; Xu JR; Li HX; Wang YS; Wen YJ; Wang XD; Yang HS; Li YH; Luo F; Wu Y; Liu YY; Yang L
Hum Gene Ther; 2011 Sep; 22(9):1061-9. PubMed ID: 21615297
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression.
Yu H; Wu J; Li H; Wang Z; Chen X; Tian Y; Yi M; Ji X; Ma J; Huang Q
Biochem Biophys Res Commun; 2007 Oct; 361(4):946-52. PubMed ID: 17692288
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Fukasawa M; Korc M
Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK
Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
Bendrik C; Robertson J; Gauldie J; Dabrosin C
Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
[TBL] [Abstract][Full Text] [Related]
39. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
40. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]